400 related articles for article (PubMed ID: 26472464)
1. Porcine Mx1 fused to HIV Tat protein transduction domain (PTD) inhibits classical swine fever virus infection in vitro and in vivo.
Zhang X; Jing J; Li W; Liu K; Shi B; Xu Q; Ma Z; Zhou B; Chen P
BMC Vet Res; 2015 Oct; 11():264. PubMed ID: 26472464
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of the replication of classical swine fever virus by porcine Mx1 protein.
He DN; Zhang XM; Liu K; Pang R; Zhao J; Zhou B; Chen PY
Antiviral Res; 2014 Apr; 104():128-35. PubMed ID: 24500530
[TBL] [Abstract][Full Text] [Related]
3. Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.
Zhou J; Chen J; Zhang XM; Gao ZC; Liu CC; Zhang YN; Hou JX; Li ZY; Kan L; Li WL; Zhou B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343573
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
6. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
[TBL] [Abstract][Full Text] [Related]
9. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
[TBL] [Abstract][Full Text] [Related]
10. Porcine Viperin protein inhibits the replication of classical swine fever virus (CSFV) in vitro.
Li W; Mao L; Cao Y; Zhou B; Yang L; Han L; Hao F; Lin T; Zhang W; Jiang J
Virol J; 2017 Oct; 14(1):202. PubMed ID: 29061156
[TBL] [Abstract][Full Text] [Related]
11. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
[TBL] [Abstract][Full Text] [Related]
12. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
[TBL] [Abstract][Full Text] [Related]
13. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.
van Gennip HG; Bouma A; van Rijn PA; Widjojoatmodjo MN; Moormann RJ
Vaccine; 2002 Feb; 20(11-12):1544-56. PubMed ID: 11858861
[TBL] [Abstract][Full Text] [Related]
14. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
15. Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.
Madera R; Gong W; Wang L; Burakova Y; Lleellish K; Galliher-Beckley A; Nietfeld J; Henningson J; Jia K; Li P; Bai J; Schlup J; McVey S; Tu C; Shi J
BMC Vet Res; 2016 Sep; 12(1):197. PubMed ID: 27612954
[TBL] [Abstract][Full Text] [Related]
16. Guanylate-Binding Protein 1, an Interferon-Induced GTPase, Exerts an Antiviral Activity against Classical Swine Fever Virus Depending on Its GTPase Activity.
Li LF; Yu J; Li Y; Wang J; Li S; Zhang L; Xia SL; Yang Q; Wang X; Yu S; Luo Y; Sun Y; Zhu Y; Munir M; Qiu HJ
J Virol; 2016 May; 90(9):4412-4426. PubMed ID: 26889038
[TBL] [Abstract][Full Text] [Related]
17. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
[TBL] [Abstract][Full Text] [Related]
18. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
20. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
